Time
00:27
Biotech company Propanc raises $100 million for cryptocurrency reserves and cancer therapy research.
November 11, 2025
CoinFeed News
Digital asset finance firm Propanc Biopharma (NASDAQ: PPCB) said Monday it has secured up to $100 million in funding from Hexstone Capital, a family office active in Bitcoin, Ethereum, Solana, Dogecoin and other digital assets.